Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM)

US6994970B1 · kind B1 · utility

Assignee

• Fresenius Medical Care Affina GmbH · DE

Inventors

• Wolfgang Rönspeck · Berlin, DE
• Rudolf Kunze · Berlin, DE
• Gerd Wallukat · Berlin, DE
• Manuela Dierenfeld · Hohen Neuendorf, DE

Key dates

• Filing date: Sep 21, 2000
• Grant date: Feb 7, 2006
• Expiry date: Oct 6, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Peptides which bind auto-antibodies being in a causally pathological relationship with dilatative cardiomyopathy are described. The peptides may be bound, for example, to a solid phase. Auto-antibodies can be removed by treating blood of patients suffering from DCM with the peptides according to the invention.